Production (Stage)
Seres Therapeutics, Inc.
MCRB
$7.05
-$0.04-0.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -47.07% | -75.94% | -60.67% | -68.96% | 4.36% |
| Total Receivables | -62.78% | -- | -- | 146.08% | -- |
| Inventory | -- | -- | -- | 892.45% | -- |
| Prepaid Expenses | -3.00% | -27.78% | -32.92% | -27.03% | -51.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -60.00% | -77.95% | -65.98% | -40.59% | 42.30% |
|
|
|||||
| Total Current Assets | -60.00% | -77.95% | -65.98% | -40.59% | 42.30% |
| Net Property, Plant & Equipment | -28.35% | -14.43% | -27.49% | -9.85% | -6.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -83.04% | -88.43% | -52.21% | 146.59% | 145.52% |
| Total Assets | -51.89% | -61.01% | -51.39% | -20.83% | 26.30% |
|
|
|||||
| Total Accounts Payable | -58.46% | 12.03% | -7.86% | -62.78% | -57.56% |
| Total Accrued Expenses | -84.49% | -52.38% | -9.68% | 76.61% | 106.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.45% | 55.25% | 32.90% | 68.10% | 84.64% |
| Total Finance Division Other Current Liabilities | -68.67% | -73.48% | -31.22% | 45.71% | 62.14% |
| Total Other Current Liabilities | -68.67% | -73.48% | -31.22% | 45.71% | 62.14% |
| Total Current Liabilities | -68.19% | -58.22% | -18.17% | 39.00% | 54.31% |
|
|
|||||
| Total Current Liabilities | -68.19% | -58.22% | -18.17% | 39.00% | 54.31% |
| Long-Term Debt | -- | -- | -- | 1.74% | 99.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -22.10% | -9.48% | -18.69% | -5.41% | -3.14% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -98.05% | -98.35% | -95.16% | -1.36% | 0.88% |
| Total Liabilities | -71.64% | -68.76% | -59.56% | 6.52% | 26.07% |
|
|
|||||
| Common Stock & APIC | 3.89% | 6.27% | 7.00% | 5.75% | 7.98% |
| Retained Earnings | 7.16% | 0.01% | -2.72% | -18.23% | -8.84% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 184.48% | 130.73% | 258.16% | -485.04% | -24.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 184.48% | 130.73% | 258.16% | -485.04% | -24.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 184.48% | 130.73% | 258.16% | -485.04% | -24.79% |
|
|
|||||